Premier Diagnostic Health Services Inc.: Placement Further Extended to Meet Subscriber Requests

VANCOUVER, BRITISH COLUMBIA--(Marketwire - Sept. 14, 2011) - Premier Diagnostic Health Services Inc. (CNSX:PDH) -

NOT FOR DISSEMINATION IN THE UNITED STATES OF AMERICA

Premier Diagnostic Health Services Inc. ("PDH") today announced that it has further extended its August 22, 2011 offering to shareholders of the Company who are accredited investors, for 3,125,000 units at $0.08 per unit for a total investment of $250,000. Each unit consists of one common share of PDH and one purchase warrant to subscribe for a further share of PDH at $0.10 per share. The warrants are non-transferable and will expire on September 30, 2013.

This offering will now expire at 2:00 p.m. on September 21, 2011, instead of September 14, 2011. The offering is close to being fully subscribed and, as some shareholders have only just indicated an intention to subscribe, the further extension will enable them to complete their subscriptions.

PDH is conducting this private placement with internal resources only. The funds from this offering will be used to implement PDH's Business Plan (dated August 22, 2011) to deliver management, quality, and financial services to hospitals seeking to increase their medical diagnostics capacity and capability, and for general working capital purposes.

More details about the Business Plan, term sheet, subscription form, and authorized representatives are available on the company's website www.premierdiagnostics.ca.

Except for historical information contained herein, this news release contains forward-looking statements that involve risks and uncertainties. Actual results may differ materially. More detailed information about potential factors that could affect financial results is included in the documents filed from time to time with the Canadian securities regulatory authorities by Premier. (Not for dissemination in the United States of America).

About Premier Diagnostic Health Services Inc. ("PDH")

Premier is a Canadian company accelerating international access to advanced medical diagnostic tools and skills. The Company's vision is to provide services and partnership opportunities that support "improving medical decisions" around the world. The Company's approach involves building long-term relationships covering management, quality, and financial services that are necessary to build, operate, and grow hospitals' diagnostic capacity and capability.